A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

The agency said it will evaluate whether further regulatory action is needed after investigating the deaths of two patients ...

The U.S. Food and Drug Administration (FDA) has announced a three-month extension for its review of the supplemental New Drug ...

Medically reviewed by Katlein Franca, MD Eczema is a chronic (long-lasting) inflammatory condition that causes rashes of scaly, irritated, itchy, dry skin. Affected areas can change color and harden.

A study published in 2020 looked at medical records of more than 500,000 adults (over 18) with atopic eczema, and more than 2.5 million without the skin condition.

Eczema can be triggered or exacerbated by a wide range of factors, including genetics, environmental factors, and allergies. Eczema is a challenging condition for both children and their parents, but ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Atopic dermatitis (AD), a chronic skin disorder characterized by inflammation, eczema-like lesions, and severe itching, is particularly prevalent in children. Recent meta-analyses have focused ...

If you have eczema, you may be using medication to manage it as well as applying over-the-counter moisturizers. Maybe you’re also curious about home remedies and wondering whether applying a ...

"We know that genetics affects the risk of eczema in children, and previous studies had already shown a protective effect of dogs, but this is the first study to explain the molecular mechanism ...

Children who are genetically prone to eczema, an itchy skin condition, are less at risk if exposed to a dog early in life, a study suggests. Advertisement. Wellness. Lifestyle Health & Wellness.